The global systemic sclerosis treatment market, valued at USD 1.0 Billion in 2023, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 7.9%, reaching a projected valuation of USD 2.2 Billion by 2033. This surge in market size is driven by increasing global prevalence, enhanced awareness, and the continuous development …